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Abstract 
Genes of the Wnt and Frizzled class, expressed in HNSCC tissue and cell lines, have an established role in 
cell morphogenesis and differentiation, and also they have oncogenic properties. We studied Wnt and Fz 
genes as potential tumor-associated markers in HNSCC by qPCR. Expression levels of Wnt and Fz genes in 
22 unique frozen samples from HNSCC were measured. We also assessed possible correlation between the 
expression levels obtained in cancer samples in relation to clinicopathologic outcome. Wnt-1 was not 
expressed in the majority of the HNSCC studied, whereas Wnt-5A was the most strongly expressed by the 
malignant tumors. Wnt-10B expression levels were related with higher grade of undifferentiation. Related to 
Fz genes, Fz-5 showed more expression levels in no-affectation of regional lymph nodes. Kaplan–Meier 
survival analyses suggest a reduced time of survival for low and high expression of Wnt-7A and Fz-5 mRNA, 
respectively. qPCR demonstrated that HNSCC express Wnt and Fz members, and suggested that Wnt and Fz 
signaling is activated in HNSCC cells. 
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Introduction 
Squamous cell carcinoma (SCC) is the most frequent malignant tumor of the head and neck 
area. In the last years, there has been great progress in identifying molecular changes that occur 
during the malignant transformation of cells. 
 
Although many molecular markers have been evaluated, the role of Wnt and Fz in 
carcinogenesis of HNSCC remains poorly understood. The diverse receptor–ligand pairs of the 
Wnt and Frizzled families play essential roles in the regulation of the cell growth, motility, and 
differentiation during embryonic development [1, 2]. Genes of the wingless (Wnt) and frizzled 
(Fz) class have an established role in cell morphogenesis and cellular differentiation [3–5]. 
  
Wnt genes encode a large family of secreted glycoproteins expressed in species ranging from 
Drosophila to human. The Wnt family constitutes 19 members in the human genome. The Wnt 
glycoproteins are ligands for the Fz receptors, which exert their effects through activation of 
distinct intracellular signaling pathways. The intracellular Wnt signaling have been recognized in 
four distinct branches: the canonical β-catenin pathway, which activates the target genes in the 
nucleus; the planar cell polarity pathway, which involves JNK (Jun N-terminal kinase) and 
cytoskeletal rearrangements; the Wnt/Ca
2+
 pathway, which involves activation of PLC 
(phospholipase C) and PKC (protein kinase); and a pathway that regulates spindle orientation and 
asymmetric cell division [6–10]. 
 
Aberrant activation of the Wnt signaling pathway has been reported during neoplastic 
progression, and became evident in cancer with the discovery that a number of Wnt genes have 
now been associated with the development of various human cancers [11–17]. 
 
To date, different roles for Wnt have been recognized in squamous cell carcinomas of the oral 
cavity [18, 19]. Also, it is known that Wnt and Fz proteins are expressed in HNSCC cell lines, 
suggesting that they play a role in cell growth and survival. However, no examination has been 
made on Wnt and Fz expression in human oral carcinomas specimens by qPCR. 
 
In the present study, we have studied expression levels of Wnt and Fz family members. The 
hypothesis that prompted this study was that human HNSCC might show different Wnt and Fz 
expression patterns than to those shown in tumor cell lines. We examined frozen human samples 
of HNSCC for the expression of five Wnt and two Fz genes. 
Materials and methods 
Processing of clinical tissue specimens 
Fresh primary tumor samples of head and neck squamous cell carcinomas (HNSCC) from 22 
patients, who underwent surgical removal of their tumors, were obtained from the Maxillofacial 
Surgery Service, A Coruña University Hospital. Among the total specimens, 22 samples 
comprised central tumor tissue and 16 comprised peritumoral tissue; both tissues were obtained 
from the same HNSCC patient (Table 1). As control, a pool of healthy human oral mucosa (n = 19) 
was used. The study was approved by the Institutional Review Board of the Ethic Committee of 
Clinical Investigation of Galicia (Spain). All tumor samples were confirmed by histopathological 
analysis. Tissue samples were dissected under stringent sterile conditions to prevent RNA 
contamination and immediately were frozen in liquid nitrogen and stored at −80°C until RNA 
extraction.  
RNA extraction 
Isolation of total RNA from frozen healthy and malignant specimens was performed, following 
manufacturer’s protocols, using Tripure Isolation Reagent (Roche, Mannheim, Germany). 
 
For the isolation of each tissue sample, 50 to 100 mg was processed. Total RNA were treated 
with DNase I. 
 
RNA integrity was confirmed by 2% agarose gel electrophoresis stained with ethidium 
bromide. RNA was also assessed for quantity at 260 nm using a GENIOUS UV 
spectrophotometer. A260/A280 relation was calculated for quality, quantity, and purity. 
  
Table 1. Clinicopathologic data from tumors analyzed 
N Localization Type G Stage TNM Gender Age (years) 
        
1 Tongue SCC 4 IV T4N1M1 F 60 
2 Tongue SCC 1 IV T3N0M0 M 80 
3 Floor of mouth SCC 3 IV T4N2M0 M 47 
4 Oropharynx SCC 1 II T2N0M0 M 71 
5 Tongue SCC 2 III T2N1M0 M 65 
6 Retromolar trigone SCC 3 III T3N0M0 M 73 
7 Floor of mouth SCC 3 III T2N1M0 M 54 
8 Floor of mouth SCC 3 IV T1N2M0 M 44 
9 Cheek SCC 1 IV T4N0M0 M 80 
10 Oropharynx SCC 2 IV T3N2M0 M 55 
11 Tongue SCC 2 IV T4N1M1 F 39 
12 Tongue SCC 1 II T2N1M0 M 52 
13 Palate SCC 2 IV T1N2M0 M 49 
14 Tongue SCC 3 IV T3N0M0 M 64 
15 Floor of mouth SCC 2 IV T4N0M0 M 55 
16 Tongue SCC 2 IV T2N2M0 M 75 
17 Retromolar trigone SCC 2 IV T4N0M0 M 73 
18 Maxilla SCC 2 IV T4N0M0 M 61 
19 Oropharynx SCC 2 II T2N0M0 F 53 
20 Tongue SCC 1 II T2N0M0 M 56 
21 Retromolar trigone SCC 1 I T1N0M0 M 65 
22 Maxilla SCC 3 IV T4N0M0 M 69 
        
 
Characteristics of the head and neck tumors analyzed 
SCC squamous cell carcinoma, TNM TNM status, F female, M male 
cDNA synthesis 
Reverse-transcription PCR (RT-PCR) was performed using Super-Script™ First-Strand 
Synthesis System for RT-PCR (Invitrogen, Spain) up to a total volume of 20 µl. One microgram of 
total RNA, 2.5 nM random hexamers, 0.5 mM dNTP mix, and 3 µl of DEPC-treated water were 
denatured at 65°C for 5 min and chilled on ice for at least 1 min. On the other hand, 2 µl of 10× 
RT buffer, 5 mM MgCl2, 0.01 M DTT, and 40 U of RNase-OUT™ Recombinant Ribonuclease 
Inhibitor were mixed, collected by centrifugation, and incubated at 25°C for 2 min. After 
incubation, 50 U of Super-Script™ II RT was added and incubated at 25°C for 10 min, 42°C for 
50 min, and 70°C for 15 min in a Thermocycler (Gene AMP PCR System 9700, Applied 
Biosystems, Spain). Finally, samples were chilled on ice and incubated with 2 U of RNAse H for 
20 min at 37°C before proceeding to the amplification of the target cDNA. Positive and negative 
controls were included in each experiment. 
 
RNA extraction, reverse-transcription PCR assay setup, and post reverse-transcription PCR 
product analysis were carried out in separate designated rooms to prevent cross-contamination. 
cDNA was quantified and assessed for purity using a Genious UV spectrophotometer. cDNA 
concentration was measured at 260 nm. Also, A260/A280 relation was calculated in order to know 
cDNA quality, quantity, and purity. 
  
Quantitative real-time PCR (qPCR) 
Quantitative real-time PCR analysis was performed, using LightCycler® 480 SYBR Green I 
Master Kit (Roche), on a LightCycler® 480 Real Time PCR System (Roche). PCR reaction 
consisted of 10 µl of Master Mix 2× conc., 0.35 μM of each forward and reverse primer, template 
cDNA, and PCR-grade water up to a final volume of 20 µl in the LightCycler 480 Multiwell 
Plate 96. Multiwell plate was centrifuged at 3,000 rpm for 2 min and was loaded in the 
LightCycler 480 Instrument until the PCR program started. An initial activation at 95°C for 5 min 
followed by an amplification target sequence 50 cycles of 95°C for 10 s, 59–60°C (depending on 
the primers pair used) for 10 s, and 72°C 9–20 s (depending on the amplicon size amplified) was 
used. For melting curve analysis, one cycle of 95°C for 5 s, 70°C for 15 s, and 95°C for 1 s was 
used. Finally, a cooling step was used at 40°C for 10 s. PCR primers for the amplification of the 
different Wnt and Fz genes were carefully designated using the web-based ProbeFinder software 
(Universal ProbeLibrary Design Center) accessible at [43] or via Roche Applied Science home 
page [44]. PCR primers were positioned to span exon–intron boundaries in order to reduce the risk 
of detecting genomic DNA. Primers were purchased from Roche Mannheim (Germany). The 
following list summarizes the primer pairs used: Wnt-1: 5′ TCT TCG GCA AGA TCG TCA A 3′ 
(forward); 5′ ACA CGT GCA GGA TTC GAT G 3′ (reverse). Wnt-5A: 5′ TGG TGC CTG ATA 
TCT CAA AGT C 3′ (forward); 5′ GAG AAA TAA CCC CAG AGT AAA CTG TAA 3′ 
(reverse). Wnt-7A: 5′ GGG AAG GAG CTC AAA GTG G 3′ (forward); 5′ CTG GCC TTG CYY 
CYC TTT GT 3′ (reverse). Wnt-10B: 5′ AAT GCG AAT CCA CAA CAA CA 3′ (forward); 5′ 
TCC AGC ATG TCT TGA ACT GG 3′ (reverse). Wnt-13: 5′ AAG ATG GTG CCA ACT TCA 
CCG 3′ (forward); 5′ CTG CCT TCT TGG GGG CTT TGC 3′ (reverse). Fz-2: 5′ CAT CGA GGC 
CAA CTC TCA GT 3′ (forward); 5′ AGG CCT ACG AAG CAC ACG 3′ (reverse). Fz-5: 5′ TAC 
CCA GCC TGT CGC TAA AC 3′ (forward); 5′ GGA TTC CAG GGA AAG GAC TCT 3′ 
(reverse). HPRT: 5′ TGA CCT TGA TTT ATT TTG CAT ACC (forward); 5′ CGA GCA AGA 
CGT TCA GTC CT 3′ (reverse). Suitable selection of housekeeping gene was performed using 
Human Endogenous Control Gene Panel (TATAA Biocenter, Sweden). The Excel macro named 
GeNorm VBA applet for Microsoft Excel was used to determine the gene with the most correlated 
expression in the set of samples. HPRT (hypoxanthine-guanine phosphoribosyltransferase) was 
used as internal control. Also, housekeeping gene was used to verify integrity of RNA and efficacy 
of reverse transcription. Any specimen with inadequate housekeeping mRNA level was excluded 
from the study. 
 
We verified that amplifications and the expected size of each qPCR product were specific. 
Agarose gel electrophoresis (1.8%) of all PCR products revealed a single band that corresponded 
to the single-amplified products as predicted by the melting curve analysis of the PCR. The 
amplification efficiency was determined for both target and housekeeping genes and was equal 
(99–100%). 
 
Data analysis was performed with LightCycler® 480 Relative Quantification software (Roche). 
Relative expression levels (R.E.L) were calculated by the 2
−ΔΔCt
 method [20]. Each assay was done 
at least in triplicate and it included marker-positive and marker-negative controls and reagent with 
no template controls. 
DNA sequencing 
Al least one qPCR product coming from each quantitative real-time PCR experiment was used 
as template DNA in order to verify the specificity of the amplified amplicon. Products were 
purified by enzymatic method (ExoSAP-IT, Amersham USB). DNA sequencing was performed on 
an ABI 3700 system (Applied Biosystems) using Big Dye terminators. Forward and reverse 
primers used in sequencing reactions were the same as for the real-time PCR. 
  
Statistical analysis 
Statistical analysis of the results was performed with SPSS program (version 12.0 for 
Windows). The relationship between Wnt and Fz expression values and clinicopathological data 
was studied by non-parametric statistic, Kruskal–Wallis, and Mann–Whitney U tests. The 
relationship among the different markers tested with patient’s survival was performed by Cox 
regression and Kaplan–Meier curves analyses. Statistical significance of differences was evaluated 
at the 95% confidence level; p values <0.05 were considered to be significant. 
Other procedures 
Standard procedures for manipulation of nucleic acids were essentially those previously 
reported [21]. 
Results 
Expression of Wnt genes in head and neck squamous cell carcinoma and healthy human oral 
mucosa of head and neck 
To assay Wnt gene expression as potential tumor-associated markers in HNSCC, we analyzed 
various tumors by qPCR. With the exception of Wnt-1, all the genes tested showed expression in 
peritumoral and central tumor tissues of oral mucosa. Of the Wnt genes, Wnt-1 was not expressed 
in the majority of the HNSCC studied; only three cases showed expression. Wnt-5A was the most 
strongly expressed by the central zones of the malignant tumors, followed by Wnt-13, Wnt-10B, 
and Wnt-7A. Regarding peritumoral tissues, Wnt-5A was also the most strongly expressed, 
followed by Wnt-10B, Wnt-13, and Wnt-7A. Wnt-5A, Wnt-7A, and Wnt-13 showed higher 
mRNA expression levels in central tumor tissues than in the peritumoral zones (Fig. 1a). When we 
compared Wnt mRNA expression levels in human central tumor tissues against healthy human 
oral mucosa, we observed that the higher levels were obtained in central tumor zones (Fig. 1b). 
When we compared Wnt mRNA expression levels in human peritumoral tissues against healthy 
human oral mucosa, we observed that the higher levels were obtained in peritumoral zones 
(Fig. 1c).  
  
 
 
 
Fig. 1. Wnt and Fz mRNA expression levels in different human HNSCC, peritumoral zone (PZ Cancer, 
n = 16) versus central tumor zone of the tumor (CZ Cancer, n = 22) (a). Wnt and Fz mRNA expression 
levels in a pool of healthy human oral mucosa (n = 19) versus central tumor tissue (CZ Cancer, n = 22) 
(b). Wnt and Fz mRNA expression levels in a pool of healthy human oral mucosa (n = 19) versus 
peritumoral tissue (PZ Cancer, n = 16) (c). Y axis represents Wnt and Fz mRNA relative expression levels 
(R.E.L.) and X axis represents the different human Wnt and Fz genes tested. mRNA levels were measured 
by quantitative real-time PCR as described in Materials and methods. Quantitative real-time PCR results 
are the mean of at least three independent measurements. Data were normalized versus the values 
obtained in healthy human oral mucosa which were considered equal to 1 
Expression of Fz genes in head and neck squamous cell carcinoma and healthy human oral 
mucosa of head and neck 
To assay Fz gene expression as potential tumor-associated markers in HNSCC, we analyzed 
various tumors by qPCR. Both genes tested showed expression in peritumoral and central tumor 
tissues of oral mucosa. Of the Fz genes, Fz-2 was the most strongly expressed by the central tumor 
zones of the malignant tumors, followed by Fz-5. Regarding peritumoral tissues, Fz-2 was the 
most strongly expressed, followed by Fz-5 (Fig. 1a). When we compared Fz mRNA expression 
levels in human central tumor tissues against healthy human oral mucosa, we observed that the 
higher levels were obtained in central tumor zones (Fig. 1b). When we compared Fz mRNA 
expression levels in human peritumoral tissues against healthy human oral mucosa, we observed 
that the higher levels were obtained in peritumoral zones (Fig. 1c). 
  
Correlation of Wnt and Fz gene expression with clinicopathological parameters and patient’s 
survival 
mRNA expression levels of the different Wnt genes tested in central tumor zones were 
correlated, by means of non-parametric statistics, with different clinicopathological parameters 
that included TNM status, stage, tumor localization, degree of differentiation, sex, and age 
(Table 2). Among all Wnt genes, WNT10B expression levels were correlated with higher grade of 
undifferentiation (Mann–Whitney U test, p = 0.013). Related to Fz genes, Fz-5 showed higher 
expression in no-affectation of regional lymph nodes (Mann–Whitney U test, p = 0.009). Fz-5 was 
not correlated with TNM status (Kruskal–Wallis test, p > 0.05), although it could seem to exist a 
direct relation between them. More tumor specimens of HNSCC should be screened to validate 
these findings.  
Table 2. Correlation among different expression levels and clinicopathologic data 
Variable % Wnt-1 Wnt-5A Wnt-7A Wnt-10B Wnt-13 Fz-2 Fz-5 
Sex 
Male 86.4 p > 0.05a p > 0.05a p > 0.05a p > 0.05a p > 0.05a p > 0.05a p > 0.05a 
Female 13.6 
       
Stage 
I 4.5 
       
II 18.2 p > 0.05b p > 0.05b p > 0.05b p > 0.05b p > 0.05b p > 0.05b p > 0.05b 
III 13.7 
       
IV 63.6 
       
T 
T1 13.6 
       
T2 31.8 p > 0.05b p > 0.05b p > 0.05b p > 0.05b p > 0.05b p > 0.05b p > 0.05b 
T3 18.2 
       
T4 36.4 
       
N 
N0 54.6 p > 0.05a p > 0.05a p > 0.05a p > 0.05a p > 0.05a p > 0.05a p = 0.009a 
N1, N2 45.4 
       
M 
M0 90.9 p > 0.05a p > 0.05a p > 0.05a p > 0.05a p > 0.05a p > 0.05a p > 0.05a 
M1 9.1 
       
G 
G1 27.3 p > 0.05a p > 0.05a p > 0.05a p = 0.013a p > 0.05a p > 0.05a p > 0.05a 
G2, G3, G4 72.7 
       
Localization 
Tongue 36.4 
       
Mouth floor 18.2 
       
Alveolar ridge 4.5 
       
Retromolar trigone 9.1 p > 0.05b p > 0.05b p > 0.05b p > 0.05b p > 0.05b p > 0.05b p > 0.05b 
Oropharyx 13.7 
       
Cheek 4.5 
       
Palate 4.5 
       
Maxilla 9.1 
       
         
 
Correlation between Wnt and Fz expression status and various clinicopathologic variables 
a Mann–Whitney U test, b Kruskal–Wallis test 
 
  
In order to know if there is any relationship among the different markers tested and patient’s 
survival, we performed Cox regression and Kaplan–Meier curves analyses. Cox regression 
analyses showed that there is no statistically significant relationship among the different markers 
studied with patient’s survival. However, when we performed Kaplan–Meier curves analyses, 
using the median of the R.E.L for each marker tested as cut-off value, we could appreciate that for 
Wnt-7A and Fz-5 we obtained values with statistical significance. Regarding Wnt-7A marker, we 
suggest that patients with R.E.L above the median (median = 1.056) have higher survival than 
those with R.E.L. below the median (p = 0.024). Also, for Fz-5 marker, we suggest that patients 
with R.E.L. above the median (median = 5.859) have lower survival than those with R.E.L. below 
the median (p = 0.011). In this way, Kaplan–Meier survival analyses suggest a reduced time of 
survival for low R.E.L. of Wnt-7A mRNA and for high R.E.L. of Fz-5 mRNA (Fig. 2). 
 
 
 
Fig. 2. Kaplan–Meier graphs for time of survival according to R.E.L. of Wnt-7A (a) and Fz-5 (b) mRNA 
in central tumor tissue of HNSCC; p values are given for log rank tests 
Discussion 
To evaluate Wnt and Fz gene expression as potential tumor-associated markers in HNSCC, we 
screened various tumors by qPCR. The results revealed that Wnt-5A was the most strongly 
expressed by the central tumor tissues, but Wnt-1 was not expressed in the majority of the HNSCC 
studied (only three cases expressed Wnt-1). On the contrary, Rhee et al. [14] observed that Wnt-1 
was one of the most expressed in HNSCC cell lines besides Wnt-10B and Wnt-5A. Also, they 
observed no differences in Fz-5 expression in HNSCC cell lines against normal human broncho-
epithelial and oral squamous epithelial cell lines, whereas in HNSCC tissues we obtained an 
increased expression of Fz-5 with regard to healthy human oral mucosa. Among all Wnt genes, 
expression levels of Wnt-10B in central tumor zone were related with higher grade of 
undifferentiation. The present study demonstrates that HNSCC express Wnt and Fz members and 
that all Wnt and Fz genes tested were overexpressed not only in peritumoral zone but also in 
central tumor tissues of human HNSCC specimens. 
 
Aberrant activation of the Wnt and Fz signaling pathway has been reported in HNSCC lines 
[14]. These investigators found that Wnt-1, Wnt-10B, Wnt-13, and Fz-2 were overexpressed in ten 
HNSCC lines in comparison to normal human bronchial epithelium, suggesting that the growth 
and survival of a subset of this tumor may depend on the Wnt/Fz pathway. Other studies focusing 
on the involvement of Wnt family expression in oral squamous cell carcinomas (OSCC) tissue 
samples and cell lines showed that carcinoma cells express many Wnt family members [18, 19]. 
 
Our finding of a weak expression of Wnt-1 and a high Wnt-10B expression not only in central 
tumor zone but also in peritumoral tissue is compatible with the idea that Wnt-1 and Wnt-10B 
have a redundant function [22]. If this is true, it may be speculated that, in differentiated HNSCC, 
Wnt-1 plays a role in the control of differentiation, proliferation, and invasiveness of cells. This 
cellular defense mechanism may subsequently be lost in undifferentiated steps and while the Wnt-
1 expression is silenced the expression of Wnt-10B is emerging in undifferentiated carcinomas. 
Wnt-1 is part of a Wnt cluster conserved in all vertebrates comprising Wnt-1 and Wnt-10B. The 
function of Wnt-10B during oncogenesis has not been explored yet. In zebrafish, Wnt-10B is 
expressed in a pattern overlapping extensively with that of Wnt-1; Wnt-1 and Wnt-10B provide 
partially redundant functions [22]. 
 
Interestingly, in human genome, Wnt-1 maps to linkage group (LG) 23 in close proximity to 
another Wnt paralog, Wnt-10B [23, 24]. The linkage of Wnt-1 and Wnt-10B paralogs has been 
conserved in the vertebrate linkage, and this relationship may reflect the existence of three ancient 
Wnt paralogs present before the divergence of protostomes and deuterostomes, Wnt-1, Wnt-6, and 
Wnt-10 [25]. The conservation of the spatial arrangement of Wnt-1 and Wnt-10B raises the 
possibility that their expression may be regulated in a coordinated and sequential fashion [26, 27]. 
In support of this assertion, a fragment of Wnt-10B gene showed an expression pattern that may be 
similar to that shown by Wnt-1 [28]. 
 
Our study demonstrates an increased expression of Wnt-10B mRNA in HNSCC, whereas Wnt-
1 expression was low or undetectable. This pattern does not fit to observations in oral squamous 
cell carcinoma lines where Wnt-1 mRNA was overexpressed [14]. This Wnt-1 strong expression 
in carcinoma cell lines but a complete loss in human head and neck squamous cell carcinomas 
could indicate a post-translational deregulation. Discrepancy between transcriptional and 
translational control fits to observations in other tumor types as aggressive invasive breast ductal 
cancers where, in the undifferentiated state, a selective loss of protein expression was found in 
parallel to an aggressive state of the tumor [29]. 
 
Although many Wnt genes have been evaluated in HNSCC, the role of Wnt-5A remains poorly 
understood. In the study of Rhee et al. [14] and in the study of Uraguchi et al. [18], Wnt-5A was 
expressed in 4/10 and 5/14 carcinoma HNSCC cells lines, respectively. In contrast, we found a 
strong expression of WNT-5A not only in peritumoral zone but also in central tumor tissue of 
HNSCC specimens. The importance of Wnt-5A signaling and their function in HNSCC are 
currently incompletely understood. It is known that in other human tumorsWnt-5A serves as an 
antagonist to the canonical Wnt signaling pathway with tumor suppressor activity in differentiated 
carcinomas. Also, Wnt-5A expression is compatible with the idea that Wnt-5A has a tumor 
activity; Wnt-5A plays a role in the control of tumor differentiation, proliferation, and 
invasiveness of cells [30–33]. 
 
While some Wnt genes, expressed in normal tissues during embryonic or post-natal period, 
induce cell morphological changes and cellular differentiation, the same Wnt genes can be 
expressed in both normal adult and tumoral tissues. These disappointing behaviors suggest that 
members of the Wnt family implicated in normal physiologic tissue development or repair are not 
expressed when the tissue has ceased proliferating and exhibit overexpression in hyperplastic or 
oncogenic transformation. Wnt proteins have a different function in carcinogenesis, and based on 
their ability to transform mouse mammary epithelial cells, they can be divided into three different 
classes: Wnt-1, Wnt-3A, and Wnt-7A have the greatest transforming capacity; Wnt-2, Wnt-5B, 
and Wnt-7B have an intermediate transforming capacity; and Wnt-4, Wnt-5A, and Wnt-6 are non-
transforming [34]. Although detailed mechanisms are not well understood why Wnts are 
overexpressed in one tumor and downregulated in another, the pleiotropism of Wnt signaling is 
evident [35]. Previous results confirmed that some components of the Wnt family have aberrant 
expression that affects the tumor proliferation in non-small cell lung carcinomas (NSCLCs) [36–
38]. 
 
The present study demonstrated that HNSCC of the oral cavity express a set of Wnt and Fz 
genes, and suggests as in other published works that this signaling pathway is activated in 
carcinoma cells. The implication of both Wnt and Fz signaling pathways in the pathogenesis of 
human cancer is becoming more clearly understood [39–41]. A recent work demonstrated a 
relationship among Wnt signaling pathway and expression values of COX-2 and Ku [42]. If more 
Wnt gene expression in HNSCC are studied in the future, the role of the Wnt pathway during oral 
squamous cell carcinoma induction and its significance in HNSCC will be well understood. 
Development of targeted therapies and novel drugs, perhaps based on Wnt-7A, Wnt-10B, and Fz-
5, could represent an attractive field for suppression of tumor progression. 
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